New study links DNA methylation in GLP1R gene to obesity without metabolic disorders

The study investigates the role of epigenetic changes in GLP1R gene polymorphisms on metabolically healthy obesity (MHO), revealing that apart from genetic variations, DNA methylation significantly influences the occurrence of MHO.

For the Sake of Your Kidneys, Think Twice About Reaching for the Salt Shaker

Adding salt to food, even just sometimes, was significantly associated with a higher risk for chronic kidney disease (CKD), a large prospective cohort study showed.

December 30, 2023

Next-gen obesity treatment from Novo Nordisk misses mark in pivotal trial

Novo Nordisk’s next-generation obesity candidate led patients to lose a substantial amount of weight in a pivotal study but fell short of expectations, results that

December 20, 2024

Opioid settlement payouts to localities made public for first time

Thousands of local governments nationwide are receiving settlement money from companies that made, sold, or distributed opioid painkillers, like Johnson & Johnson, AmerisourceBergen, and Walmart.

June 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.